LAS VEGAS, Sept. 24, 2009 (GLOBE NEWSWIRE) -- Savvy companies will stand back and look at their core technologies and ask themselves, "How else can we sell it?" Many investors will recall the rush of technology and biotechnology into the Homeland Defense sector some years ago and the adaption to security needs. Products always follow dollars for certain, but when an existing concept or product that already has years and expense built into its initial technology can be adapted to a new realm of opportunity, a company can find itself hypothetically in a situation with better margins and perhaps rising opportunity.
This may well turn out to be the case for E-18 Corp. (OTCBB:ETEN), which announced after market yesterday the completion of the U.S. patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market in addition to its efforts as a medical device company.
E-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices, develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim.
A company profile of E-18 Corp and of interest to investors of medical device leaders Medtronic Inc (NYSE:MDT), Varian Medical Systems (NYSE:VAR), NxStage Medical Inc. (Nasdaq:NXTM), and Intuitive Surgical Inc. (Nasdaq:ISRG) has been made available at www.SmallCapSentinel.com/ETEN
Please register to receive information on emerging public companies at: www.SmallCapSentinel.com/register
Watch a video demo of the product here: http://www.protectusmedical.com/flash_syringe_demo.html
Join the discussion on all aspects of the stock market at www.FiSpace.net, a social networking and blog site for investors.
Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. Small Cap Sentinel is property of Integrity Media Inc. (IMI). IMI provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies haven't always approved statements made in this report. This report is neither a solicitation to buy nor offer to sell securities but is for information purposes only and shouldn't be used as the basis for any investment decision. IMI is not an investment advisor, analyst or licensed broker dealer and this report isn't investment advice. IMI has been paid $5,000 for this report and other advertising services by Trilogy Capital Partners, a financial p.r. consultant to ETEN. Paid reports constitute a conflict of interest as to IMI's ability to remain objective in communication regarding subject companies.